Drugs / LPS
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03426995 | Mar 2018 → May 2019 | rheumatoid arthritis | GlaxoSmithKline | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LPS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03426995 ↗ |
| Route | Intravenous | “LPS will be administered as an intravenous injection” NCT03426995 ↗ |